RWJBarnabas Health Jersey City Medical Center — Jersey City, New Jersey

RWJBarnabas Health Jersey City Medical Center is a clinical research site located in Jersey City, New Jersey, United States 07302.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

RWJBarnabas Health Jersey City Medical Center has participated in 7 clinical trials with 5 currently active.

Therapeutic areas: Radiation Therapy, Metastatic Cancer, Colorectal Neoplasms.

Sponsors: Rutgers, The State University of New Jersey, Seagen, a wholly owned subsidiary of Pfizer, Mridula George, MD.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jersey City

Browse all research sites in New Jersey · View every site in Jersey City

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for RWJBarnabas Health Jersey City Medical Center?

RWJBarnabas Health Jersey City Medical Center has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has RWJBarnabas Health Jersey City Medical Center conducted?

RWJBarnabas Health Jersey City Medical Center has 7 clinical trials on record, with 5 currently active. Their work covers Radiation Therapy, Metastatic Cancer, Colorectal Neoplasms.

Is RWJBarnabas Health Jersey City Medical Center accredited by Crixeo Clinical Trials?

RWJBarnabas Health Jersey City Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about RWJBarnabas Health Jersey City Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.